Skip to main content
Top
Published in: Endocrine 2/2011

01-10-2011 | Research Letter

Gene expression profiling supports the role of Repin1 in the pathophysiology of metabolic syndrome

Authors: Jeanette Bahr, Nora Klöting, Ingrid Klöting, Niels Follak

Published in: Endocrine | Issue 2/2011

Login to get access

Abstract

Congenic BB rat strains carrying a SHR segment (D4Got41-Tacr1; 60.5–122.8 Mb; BB.4S) or a WOKW segment (D4Got41-Fabp1; 60.5–104.6 Mb; BB.4W) of chromosome 4 within the BB/OK background develop facets of the metabolic syndrome when compared with their parental BB/OK rats. To narrow down potential genes involved in the pathophysiology of metabolic syndrome, gene expression studies in adipose tissues of BB/OK, BB.4S, and BB.4W rats were initiated. Total RNA of subcutaneous and epididymal adipose tissue of BB/OK (n = 10), congenic BB.4S (n = 8), and BB.4W (n = 9) males at an age of 4 weeks was isolated. The mRNA expression of 92 genes involved in obesity, insulin resistance and other metabolic traits was measured by RT-PCR. Significant differences in gene expression were only found in Repin1 in both adipose tissues. Congenic BB.4W showed significantly lower gene expression than did BB.4S and BB/OK. Our findings and newly published findings of Repin1 in 3T3-L1 adipocytes support the hypothesis that Repin1 may affect the development of facets of the metabolic syndrome.
Literature
1.
go back to reference K.G. Alberti, P. Zimmet, J. Shaw, Metabolic syndrome—a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet. Med. 23, 469–480 (2006)PubMedCrossRef K.G. Alberti, P. Zimmet, J. Shaw, Metabolic syndrome—a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet. Med. 23, 469–480 (2006)PubMedCrossRef
2.
go back to reference S. Hulman, B. Falkner, Y.Q. Chen, Insulin resistance in the spontaneously hypertensive rat. Metabolism 40, 359–361 (1991)PubMedCrossRef S. Hulman, B. Falkner, Y.Q. Chen, Insulin resistance in the spontaneously hypertensive rat. Metabolism 40, 359–361 (1991)PubMedCrossRef
3.
go back to reference J. van den Brandt, P. Kovacs, I. Klöting, Metabolic syndrome and aging in Wistar Ottawa Karlsburg W rats. Int. J. Obes. Relat. Metab. Disord. 26, 573–576 (2002)PubMedCrossRef J. van den Brandt, P. Kovacs, I. Klöting, Metabolic syndrome and aging in Wistar Ottawa Karlsburg W rats. Int. J. Obes. Relat. Metab. Disord. 26, 573–576 (2002)PubMedCrossRef
4.
go back to reference P. Kovács, J. van den Brandt, A.C. Bonné, L.F. van Zutphen, L.A. van Lith, I. Klöting, Congenic BB.SHR rat provides evidence for effects of a chromosome 4 segment (D4Mit6-Npy approximately 1 cm) on total serum and lipoprotein lipid concentration and composition after feeding a high-fat, high-cholesterol diet. Metabolism 50, 458–462 (2001)PubMedCrossRef P. Kovács, J. van den Brandt, A.C. Bonné, L.F. van Zutphen, L.A. van Lith, I. Klöting, Congenic BB.SHR rat provides evidence for effects of a chromosome 4 segment (D4Mit6-Npy approximately 1 cm) on total serum and lipoprotein lipid concentration and composition after feeding a high-fat, high-cholesterol diet. Metabolism 50, 458–462 (2001)PubMedCrossRef
5.
go back to reference N. Klöting, B. Wilke, I. Klöting, Phenotypic and genetic analyses of subcongenic BB.SHR rat lines shorten the region on chromosome 4 bearing gene(s) for underlying facets of metabolic syndrome. Physiol. Genomics 18, 325–330 (2004)PubMedCrossRef N. Klöting, B. Wilke, I. Klöting, Phenotypic and genetic analyses of subcongenic BB.SHR rat lines shorten the region on chromosome 4 bearing gene(s) for underlying facets of metabolic syndrome. Physiol. Genomics 18, 325–330 (2004)PubMedCrossRef
6.
go back to reference N. Klöting, B. Wilke, I. Klöting, Alleles on rat chromosome 4 (D4Got41-Fabp1/Tacr1) regulate subphenotypes of obesity. Obes. Res. 13, 589–595 (2005)PubMedCrossRef N. Klöting, B. Wilke, I. Klöting, Alleles on rat chromosome 4 (D4Got41-Fabp1/Tacr1) regulate subphenotypes of obesity. Obes. Res. 13, 589–595 (2005)PubMedCrossRef
7.
go back to reference N. Klöting, I. Klöting, Congenic mapping of type 1 diabetes-protective gene(s) in an interval of 4 Mb on rat chromosome 6q32. Biochem. Biophys. Res. Commun. 323, 388–394 (2004)PubMedCrossRef N. Klöting, I. Klöting, Congenic mapping of type 1 diabetes-protective gene(s) in an interval of 4 Mb on rat chromosome 6q32. Biochem. Biophys. Res. Commun. 323, 388–394 (2004)PubMedCrossRef
8.
go back to reference I. Klöting, P. Kovacs, B. Kuttler, Phenotypic consequences after restoration of lymphopenia in the diabetes-prone BB/OK rat. Biochem. Biophys. Res. Commun. 239, 106–110 (1997)PubMedCrossRef I. Klöting, P. Kovacs, B. Kuttler, Phenotypic consequences after restoration of lymphopenia in the diabetes-prone BB/OK rat. Biochem. Biophys. Res. Commun. 239, 106–110 (1997)PubMedCrossRef
9.
go back to reference P. Trayhurn, J.H. Beattie, Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ. Proc. Soc. Nutr. 60, 329–339 (2001)CrossRef P. Trayhurn, J.H. Beattie, Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ. Proc. Soc. Nutr. 60, 329–339 (2001)CrossRef
10.
go back to reference M. Terán-García, C. Bouchard, Genetics of the metabolic syndrome. Appl. Physiol. Nutr. Metab. 32, 89–114 (2007)PubMedCrossRef M. Terán-García, C. Bouchard, Genetics of the metabolic syndrome. Appl. Physiol. Nutr. Metab. 32, 89–114 (2007)PubMedCrossRef
11.
go back to reference T. Rankinen, A. Zuberi, Y.C. Chagnon, S.J. Weisnagel, G. Argyropoulos, B. Walts, L. Pérusse, C. Bouchard, The human obesity gene map: the 2005 update. Obesity 14, 529–644 (2006)PubMedCrossRef T. Rankinen, A. Zuberi, Y.C. Chagnon, S.J. Weisnagel, G. Argyropoulos, B. Walts, L. Pérusse, C. Bouchard, The human obesity gene map: the 2005 update. Obesity 14, 529–644 (2006)PubMedCrossRef
12.
go back to reference N. Klöting, B. Wilke, I. Klöting, Triplet repeat in the Repin1 3′-untranslated region on rat chromosome 4 correlates with facets of the metabolic syndrome. Diabetes Metab. Res. Rev. 23, 406–410 (2007)PubMedCrossRef N. Klöting, B. Wilke, I. Klöting, Triplet repeat in the Repin1 3′-untranslated region on rat chromosome 4 correlates with facets of the metabolic syndrome. Diabetes Metab. Res. Rev. 23, 406–410 (2007)PubMedCrossRef
13.
go back to reference G. Shaw, R. Kamen, A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 46, 659–667 (1986)PubMedCrossRef G. Shaw, R. Kamen, A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 46, 659–667 (1986)PubMedCrossRef
14.
go back to reference K. Ruschke, M. Illes, M. Kern, I. Klöting, M. Fasshauer, M.R. Schön, J. Kosacka, G. Fitzl, P. Kovacs, M. Stumvoll, M. Blüher, N. Klöting, Repin1 maybe involved in the regulation of cell size and glucose transport in adipocytes. Biochem. Biophys. Res. Commun. 400, 246–251 (2010)PubMedCrossRef K. Ruschke, M. Illes, M. Kern, I. Klöting, M. Fasshauer, M.R. Schön, J. Kosacka, G. Fitzl, P. Kovacs, M. Stumvoll, M. Blüher, N. Klöting, Repin1 maybe involved in the regulation of cell size and glucose transport in adipocytes. Biochem. Biophys. Res. Commun. 400, 246–251 (2010)PubMedCrossRef
Metadata
Title
Gene expression profiling supports the role of Repin1 in the pathophysiology of metabolic syndrome
Authors
Jeanette Bahr
Nora Klöting
Ingrid Klöting
Niels Follak
Publication date
01-10-2011
Publisher
Springer US
Published in
Endocrine / Issue 2/2011
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-011-9497-7

Other articles of this Issue 2/2011

Endocrine 2/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.